Your browser doesn't support javascript.
loading
Experts' recommendations in laser use for the endoscopic treatment of prostate hypertrophy: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training-Research in Urological Surgery and Technology (T.R.U.S.T.)-Group.
Ortner, Gernot; Güven, Selcuk; Somani, Bhaskar Kumar; Nicklas, Andre; Scoffone, Cesare Marco; Gracco, Cecilia; Goumas, Ioannis Kartalas; Bach, Thorsten; Sancha, Fernando Gómez; Figueredo, Felipe C A; Krambeck, Amy; Bozzini, Giorgio; Lehrich, Karin; Liatsikos, Evangelos; Kallidonis, Panagiotis; Roche, Jean Baptiste; Miernik, Arkadiusz; Enikeev, Dmitry; Tunc, Lutfi; Bhojani, Naeem; Gilling, Peter; Otero, Javier Romero; Porreca, Angelo; Ahyai, Sasha; Netsch, Christopher; Gözen, Ali Serdar; Nagele, Udo; Herrmann, Thomas R W; Tokas, Theodoros.
Afiliação
  • Ortner G; Department of Urology and Andrology, General Hospital Hall i.T., Hall in Tirol, Austria. gerni_o@hotmail.com.
  • Güven S; Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group, Hall in Tirol, Austria. gerni_o@hotmail.com.
  • Somani BK; Department of Urology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey.
  • Nicklas A; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Scoffone CM; Department of Urology and Andrology, General Hospital Hall i.T., Hall in Tirol, Austria.
  • Gracco C; Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group, Hall in Tirol, Austria.
  • Goumas IK; Department of Urology, Cottolengo Hospital of Torino, Turin, Italy.
  • Bach T; Department of Urology, Cottolengo Hospital of Torino, Turin, Italy.
  • Sancha FG; Department of Urology, Istituto Clinico Beato Matteo, Vigevano, Italy.
  • Figueredo FCA; Department of Urology, Asklepios Westklinikum Rissen, Hamburg, Germany.
  • Krambeck A; Department of Urology, ICUA-Clínica CEMTRO, Madrid, Spain.
  • Bozzini G; Instituto da Próstata Aumentada, Hospital Pompéia, Caxias do Sul, Brazil.
  • Lehrich K; Department of Urology, Northwestern Medicine, Chicago, IL, USA.
  • Liatsikos E; Department of Urology, ASST Lariana, Como, Italy.
  • Kallidonis P; Department of Urology, Urological Laser Center, Vivantes Auguste-Viktoria-Hospital Berlin, Berlin, Germany.
  • Roche JB; Department of Urology, University of Patras, Patras, Greece.
  • Miernik A; Department of Urology, University of Patras, Patras, Greece.
  • Enikeev D; Department of Urology, Clinique Saint-Augustin, Bordeaux, France.
  • Tunc L; Department of Urology, University of Freiburg, Freiburg, Germany.
  • Bhojani N; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Gilling P; Karl Landstainer Institute of Urology and Andrology, Vienna, Austria.
  • Otero JR; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Porreca A; Department of Urology, Acibadem Hospital, Ankara, Turkey.
  • Ahyai S; Division of Urology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.
  • Netsch C; Department of Urology, Tauranga Hospital, University of Auckland, Auckland, New Zealand.
  • Gözen AS; ROC Clinic and HM Urological Department, Fundación Investigación HM Hospitales, HM Hospitales, Madrid, Spain.
  • Nagele U; Department of Oncological Urology, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
  • Herrmann TRW; Department of Urology, Medical University of Graz, Graz, Austria.
  • Tokas T; Department of Urology, Asklepios Klinik Barmbek, Hamburg, Germany.
World J Urol ; 41(11): 3277-3285, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37632557
ABSTRACT

PURPOSE:

To identify expert laser settings for BPH treatment and evaluate the application of preventive measures to reduce complications.

METHODS:

A survey was conducted after narrative literature research to identify relevant questions regarding laser use for BPH treatment (59 questions). Experts were asked for laser settings during specific clinical scenarios. Settings were compared for the reported laser types, and common settings and preventive measures were identified.

RESULTS:

Twenty-two experts completed the survey with a mean filling time of 12.9 min. HoYAG, Thulium fiber laser (TFL), continuous wave (cw) TmYAG, pulsed TmYAG and Greenlight™ lasers are used by 73% (16/22), 50% (11/22), 23% (5/22), 13.6% (3/22) and 9.1% (2/22) of experts, respectively. All experts use anatomical enucleation of the prostate (EEP), preferentially in one- or two-lobe technique. Laser settings differ significantly between laser types, with median laser power for apical/main gland EEP of 75/94 W, 60/60 W, 100/100 W, 100/100 W, and 80/80 W for HoYAG, TFL, cwTmYAG, pulsed TmYAG and Greenlight™ lasers, respectively (p = 0.02 and p = 0.005). However, power settings within the same laser source are similar. Pulse shapes for main gland EEP significantly differ between lasers with long and pulse shape modified (e.g., Moses, Virtual Basket) modes preferred for HoYAG and short pulse modes for TFL (p = 0.031).

CONCLUSION:

HoYAG lasers no longer seem to be the mainstay of EEP. TFL lasers are generally used in pulsed mode though clinical applicability for quasi-continuous settings has recently been demonstrated. One and two-lobe techniques are beneficial regarding operative time and are used by most experts.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Litotripsia a Laser / Terapia a Laser / Lasers de Estado Sólido Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: World J Urol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Litotripsia a Laser / Terapia a Laser / Lasers de Estado Sólido Tipo de estudo: Guideline Limite: Humans / Male Idioma: En Revista: World J Urol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria